The Procter & Gamble Company (BCBA:PG)

CTI BioPharma Revenue

In the fiscal year ending June 30, 2025, The Procter & Gamble Company had annual revenue of $84.28B USD with 0.29% growth. The Procter & Gamble Company had revenue of $20.89B in the quarter ending June 30, 2025, with 1.74% growth.

• Revenue: $84.28B
• Revenue Growth: +0.29%
• P/S Ratio: 4.72
• Revenue / Employee: $780.41K
• Employees: 108,000
• Market Cap: 474.49T

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	84.28B	245.00M	0.29%
Jun 30, 2024	84.04B	2.03B	2.48%
Jun 30, 2023	82.01B	1.82B	2.27%
Jun 30, 2022	80.19B	4.07B	5.35%
Jun 30, 2021	76.12B	5.17B	7.28%